1000+ types of tissue microarray

TISSUE ARRAYS

B-126Lu1

Lung cancer tissue array, including pathology grade, TNM and clinical stage, 63 cases/126 cores

Zoom

B-126Lu1

Cores

126

Cases

Row number

Column number

Core Diameter(mm)

1.0

Thickness(µm)

5.0

Tissue Array Type

FFPE

Species

Human

QA/QC

H&E and IHC confirmed

Applications

Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.

Notes

1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better.

2.Bake the slides for 60 minutes at 65℃ before the experiment.

3.Please choose a gentle repair method to avoid tissue detachment.

Legend:

Lun

-Lung

Malignant (IA)

Malignant (IB)

Malignant (IIA)

Malignant (IIB)

Malignant (IIIA)

Malignant (IIIB)

Malignant (IV)

NAT (*)

TISSUE ARRAYS B-126Lu1

LUN

Pos	No	Age	Sex	Organ_Anatomic_Site	Pathology_diagnosis	Grade	TNM	Stage	Type	Tumor Size
A1	1	58	F	Lung	Acinar adenocarcinoma	2	T2bN1M0	IIB	Malignant	6.55.04.5
A2	2	58	F	Lung	Acinar adenocarcinoma	2	T2bN1M0	IIB	Malignant	6.55.04.5
A3	3	62	M	Lung	Adenocarcinoma	2	T2aN0M0	IB	Malignant	4.54.03.0
A4	4	62	M	Lung	Adenocarcinoma	2	T2aN0M0	IB	Malignant	4.54.03.0
A5	5	54	M	Lung	Adenocarcinoma (adherent growth predominant)	2	T2bN2M0	IIIA	Malignant	4.04.02.5
A6	6	54	M	Lung	Adenocarcinoma (adherent growth predominant)	2	T2bN2M0	IIIA	Malignant	4.04.02.5
A7	7	65	F	Lung	Adenocarcinoma	2	T2bN2M0	IIIA	Malignant	*
A8	8	65	F	Lung	Adenocarcinoma	2	T2bN2M0	IIIA	Malignant	*
A9	9	62	M	Lung	Adenocarcinoma	2	T2aN0M0	IB	Malignant	4.03.53.0
A10	10	62	M	Lung	Adenocarcinoma	2	T2aN0M0	IB	Malignant	4.03.53.0
A11	11	65	M	Lung	Adenocarcinoma	2	T2bN0M0	IIA	Malignant	*
A12	12	65	M	Lung	Adenocarcinoma	2	T2bN0M0	IIA	Malignant	*
B1	13	48	M	Lung	Adenocarcinoma	2	T2N1M0	IIB	Malignant	*
B2	14	48	M	Lung	Adenocarcinoma	2	T2N1M0	IIB	Malignant	*
B3	15	57	M	Lung	Adenocarcinoma+(lepidic predominant)	2	T2bN0M0	IIA	Malignant	5.04.54.5
B4	16	57	M	Lung	Adenocarcinoma+(lepidic predominant)	2	T2bN0M0	IIA	Malignant	5.04.54.5
B5	17	67	M	Lung	Invasive adenocarcinoma	2	T2aN0M0	IB	Malignant	4.02.52.0
B6	18	67	M	Lung	Invasive adenocarcinoma	2	T2aN0M0	IB	Malignant	4.02.52.0
B7	19	58	F	Lung	Papillary adenocarcinoma	2	T2aN0M0	IB	Malignant	431.5
B8	20	58	F	Lung	Papillary adenocarcinoma	2	T2aN0M0	IB	Malignant	431.5
B9	21	49	M	Lung	Adenocarcinoma	2	T2N0M0	IB	Malignant	5.0
B10	22	49	M	Lung	Adenocarcinoma	2	T2N0M0	IB	Malignant	5.0
B11	23	39	F	Lung	Adenocarcinoma	2--3	T2aN0M0	IB	Malignant	*
B12	24	39	F	Lung	Adenocarcinoma	2--3	T2aN0M0	IB	Malignant	*
C1	25	71	F	Lung	Adenocarcinoma	2--3	T2N1M0	IIB	Malignant	*
C2	26	71	F	Lung	Adenocarcinoma	2--3	T2N1M0	IIB	Malignant	*
C3	27	53	M	Lung	Adenocarcinoma	3	T2N0M0	IB	Malignant	9.576
C4	28	53	M	Lung	Adenocarcinoma	3	T2N0M0	IB	Malignant	9.576
C5	29	65	M	Lung	Adenocarcinoma	3	T2aN2M0	IIIA	Malignant	5.05.03.5
C6	30	65	M	Lung	Adenocarcinoma	3	T2aN2M0	IIIA	Malignant	5.05.03.5
C7	31	40	M	Lung	Adenocarcinoma	3	T2N0M0	IB	Malignant	6.0
C8	32	40	M	Lung	Adenocarcinoma	3	T2N0M0	IB	Malignant	6.0
C9	33	64	F	Lung	Adenocarcinoma	3	T2N0M0	IB	Malignant	*
C10	34	64	F	Lung	Adenocarcinoma	3	T2N0M0	IB	Malignant	*
C11	35	68	M	Lung	Solid adenocarcinoma	3	T2N1M1	IV	Malignant	*
C12	36	68	M	Lung	Solid adenocarcinoma	3	T2N1M1	IV	Malignant	*
D1	37	58	M	Lung	Adenocarcinoma	3	T2N0M0	IB	Malignant	6.54.53.5
D2	38	58	M	Lung	Adenocarcinoma	3	T2N0M0	IB	Malignant	6.54.53.5
D3	39	58	F	Lung	Adenocarcinoma	3	T2aN0M0	IB	Malignant	*
D4	40	58	F	Lung	Adenocarcinoma	3	T2aN0M0	IB	Malignant	*
D5	41	56	F	Lung	Invasive mucinous adenocarcinoma	3	T2aN1M0	IIB	Malignant	773.5
D6	42	56	F	Lung	Invasive mucinous adenocarcinoma	3	T2aN1M0	IIB	Malignant	773.5
D7	43	62	M	Lung	Adenocarcinoma	3	T2aN0M0	IB	Malignant	*
D8	44	62	M	Lung	Adenocarcinoma	3	T2aN0M0	IB	Malignant	*
D9	45	48	F	Lung	Adenocarcinoma	3	T2AN0M0	IB	Malignant	54.03
D10	46	48	F	Lung	Adenocarcinoma	3	T2AN0M0	IB	Malignant	54.03
D11	47	48	M	Lung	Adenocarcinoma	3	T3N1M0	IIIA	Malignant	4.0
D12	48	48	M	Lung	Adenocarcinoma	3	T3N1M0	IIIA	Malignant	4.0
E1	49	56	F	Lung	Adenocarcinoma	3	T2aN1M0	IIB	Malignant	753.5
E2	50	56	F	Lung	Adenocarcinoma	3	T2aN1M0	IIB	Malignant	753.5
E3	51	43	M	Lung	Adenocarcinoma	3	T2aN0M0	IB	Malignant	5.03.02.5
E4	52	43	M	Lung	Adenocarcinoma	3	T2aN0M0	IB	Malignant	5.03.02.5
E5	53	69	M	Lung	Solid adenocarcinoma	3	T3N1M0	IIIA	Malignant	*
E6	54	69	M	Lung	Solid adenocarcinoma	3	T3N1M0	IIIA	Malignant	*
E7	55	40	M	Lung	Adenocarcinoma	3	T2N0M0	IB	Malignant	4.5
E8	56	40	M	Lung	Adenocarcinoma	3	T2N0M0	IB	Malignant	4.5
E9	57	70	M	Lung	Adenocarcinoma	3	T3N1M0	IIIA	Malignant	7.0
E10	58	70	M	Lung	Adenocarcinoma	3	T3N1M0	IIIA	Malignant	7.0
E11	59	65	M	Lung	Adenocarcinoma	3	T2N1M0	IIB	Malignant	543.5
E12	60	65	M	Lung	Adenocarcinoma	3	T2N1M0	IIB	Malignant	543.5
F1	61	48	M	Lung	Adenocarcinoma	3	T2N0M0	IB	Malignant	6.0
F2	62	48	M	Lung	Adenocarcinoma	3	T2N0M0	IB	Malignant	6.0
F3	63	67	M	Lung	Adenocarcinoma	3	T2aN0M0	IB	Malignant	3*2
F4	64	67	M	Lung	Adenocarcinoma	3	T2aN0M0	IB	Malignant	3*2
F5	65	65	F	Lung	Adenocarcinoma	3	T3N1M0	IIIA	Malignant	*
F6	66	65	F	Lung	Adenocarcinoma	3	T3N1M0	IIIA	Malignant	*
F7	67	72	M	Lung	Papillary adenocarcinoma	3	T3N0M0	IIB	Malignant	6.0
F8	68	72	M	Lung	Papillary adenocarcinoma	3	T3N0M0	IIB	Malignant	6.0
F9	69	67	M	Lung	Adenosquamous carcinoma	*	T2aN0M0	IB	Malignant	*
F10	70	67	M	Lung	Adenosquamous carcinoma	*	T2aN0M0	IB	Malignant	*
F11	71	64	M	Lung	Adenosquamous carcinoma	*	T2aN0M0	IB	Malignant	*
F12	72	64	M	Lung	Adenosquamous carcinoma	*	T2aN0M0	IB	Malignant	*
G1	73	63	M	Lung	Squamous cell carcinoma	1	T2N0M0	IB	Malignant	543.5
G2	74	63	M	Lung	Squamous cell carcinoma	1	T2N0M0	IB	Malignant	543.5
G3	75	53	M	Lung	Squamous cell carcinoma	1	T2N0M0	IB	Malignant	333
G4	76	53	M	Lung	Squamous cell carcinoma	1	T2N0M0	IB	Malignant	333
G5	77	60	M	Lung	Squamous cell carcinoma	1	T2N1M0	IIB	Malignant	433
G6	78	60	M	Lung	Squamous cell carcinoma	1	T2N1M0	IIB	Malignant	433
G7	79	30	M	Lung	Squamous cell carcinoma	1--2	T2N0M0	IB	Malignant	*
G8	80	30	M	Lung	Squamous cell carcinoma	1--2	T2N0M0	IB	Malignant	*
G9	81	50	M	Lung	Squamous cell carcinoma	1--2	T2N0M0	IB	Malignant	7.554
G10	82	50	M	Lung	Squamous cell carcinoma	1--2	T2N0M0	IB	Malignant	7.554
G11	83	51	M	Lung	Squamous cell carcinoma	1--2	T3N1M0	IIIA	Malignant	655
G12	84	51	M	Lung	Squamous cell carcinoma	1--2	T3N1M0	IIIA	Malignant	655
H1	85	65	M	Lung	Squamous cell carcinoma	2	T2aN0M0	IB	Malignant	*
H2	86	65	M	Lung	Squamous cell carcinoma	2	T2aN0M0	IB	Malignant	*
H3	87	72	M	Lung	Squamous cell carcinoma	2	T2N1M0	IIB	Malignant	731.5
H4	88	72	M	Lung	Squamous cell carcinoma	2	T2N1M0	IIB	Malignant	731.5
H5	89	46	M	Lung	Squamous cell carcinoma	2	T3N1M0	IIIA	Malignant	*
H6	90	46	M	Lung	Squamous cell carcinoma	2	T3N1M0	IIIA	Malignant	*
H7	91	69	M	Lung	Squamous cell carcinoma	2	T2N0M0	IB	Malignant	*
H8	92	69	M	Lung	Squamous cell carcinoma	2	T2N0M0	IB	Malignant	*
H9	93	63	M	Lung	Squamous cell carcinoma	2	T2bN0M0	IIA	Malignant	*
H10	94	63	M	Lung	Squamous cell carcinoma	2	T2bN0M0	IIA	Malignant	*
H11	95	58	M	Lung	Squamous cell carcinoma	2	T3N1M0	IIIA	Malignant	443
H12	96	58	M	Lung	Squamous cell carcinoma	2	T3N1M0	IIIA	Malignant	443
I1	97	69	M	Lung	Squamous cell carcinoma	2	T2N0M0	IB	Malignant	*
I2	98	69	M	Lung	Squamous cell carcinoma	2	T2N0M0	IB	Malignant	*
I3	99	69	M	Lung	Squamous cell carcinoma	2	T2N1M0	IIB	Malignant	754
I4	100	69	M	Lung	Squamous cell carcinoma	2	T2N1M0	IIB	Malignant	754
I5	101	67	M	Lung	Squamous cell carcinoma	2--3	T2N0M0	IB	Malignant	3*2.5
I6	102	67	M	Lung	Squamous cell carcinoma	2--3	T2N0M0	IB	Malignant	3*2.5
I7	103	45	M	Lung	Squamous cell carcinoma	2--3	T2N0M0	IB	Malignant	431
I8	104	45	M	Lung	Squamous cell carcinoma	2--3	T2N0M0	IB	Malignant	431
I9	105	67	M	Lung	Squamous cell carcinoma	3	T2bN1M0	IIB	Malignant	766
I10	106	67	M	Lung	Squamous cell carcinoma	3	T2bN1M0	IIB	Malignant	766
I11	107	68	M	Lung	Squamous cell carcinoma	3	T4N1M0	IIIA	Malignant	875
I12	108	68	M	Lung	Squamous cell carcinoma	3	T4N1M0	IIIA	Malignant	875
J1	109	54	M	Lung	Squamous cell carcinoma	3	T1N0M0	IA	Malignant	1.51.31.2
J2	110	54	M	Lung	Squamous cell carcinoma	3	T1N0M0	IA	Malignant	1.51.31.2
J3	111	45	F	Lung	Squamous cell carcinoma	3	T2N0M0	IB	Malignant	542.5
J4	112	45	F	Lung	Squamous cell carcinoma	3	T2N0M0	IB	Malignant	542.5
J5	113	30	M	Lung	Squamous cell carcinoma	3	T2aN0M0	IB	Malignant	4.543
J6	114	30	M	Lung	Squamous cell carcinoma	3	T2aN0M0	IB	Malignant	4.543
J7	115	56	M	Lung	Squamous cell carcinoma	3	T3N2M0	IIIB	Malignant	765
J8	116	56	M	Lung	Squamous cell carcinoma	3	T3N2M0	IIIB	Malignant	765
J9	117	35	M	Lung	Squamous cell carcinoma	3	T1bN0M0	IA	Malignant	332
J10	118	35	M	Lung	Squamous cell carcinoma	3	T1bN0M0	IA	Malignant	332
J11	119	70	M	Lung	Squamous cell carcinoma	3	T2aN0M0	IB	Malignant	*
J12	120	70	M	Lung	Squamous cell carcinoma	3	T2aN0M0	IB	Malignant	*
K1	121	41	M	Lung	Squamous cell carcinoma	3	T2N0M0	IB	Malignant	432
K2	122	41	M	Lung	Squamous cell carcinoma	3	T2N0M0	IB	Malignant	432
K3	123	54	M	Lung	Adjacent normal lung tissue	*	*	*	NAT	*
K4	124	54	M	Lung	Adjacent normal lung tissue	*	*	*	NAT	*
K5	125	62	M	Lung	Adjacent normal lung tissue	*	*	*	NAT	*
K6	126	62	M	Lung	Adjacent normal lung tissue	*	*	*	NAT	*